Page last updated: 2024-08-25

zoledronic acid and Dyspnea

zoledronic acid has been researched along with Dyspnea in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Al Baroudi, S; Collaco, JM; Dunn, E; Jabre, NA	1
Braybrooke, JP; Clive, AO; Edey, AJ; Hall, D; Hooper, CE; Kahan, BC; Lyburn, I; Lyen, SM; Maskell, NA; Milton, T; Morley, AJ; Sequeiros, I; White, P; Zahan-Evans, N	1
Archbold, P; Cheng, J; Taggart, H	1
Kantoff, P; Kaufman, DS; Michaelson, MD; Oh, WK; Smith, MR	1

Trials

2 trial(s) available for zoledronic acid and Dyspnea

Article	Year
A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study. PloS one, 2015, Volume: 10, Issue:3 Topics: Administration, Intravenous; Aged; Biomarkers; Diphosphonates; Dyspnea; Female; Humans; Imidazoles; Male; Neoplasm Metastasis; Pilot Projects; Pleura; Pleural Effusion, Malignant; Quality of Life; Safety; Treatment Outcome; Zoledronic Acid	2015
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer. Cancer, 2006, Aug-01, Volume: 107, Issue:3 Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Biomarkers, Tumor; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Disease Progression; Dyspnea; Edema; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Pyrrolidines; Treatment Outcome; Zoledronic Acid	2006

Article

Year

A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study.

PloS one, 2015, Volume: 10, Issue:3

Topics: Administration, Intravenous; Aged; Biomarkers; Diphosphonates; Dyspnea; Female; Humans; Imidazoles; Male; Neoplasm Metastasis; Pilot Projects; Pleura; Pleural Effusion, Malignant; Quality of Life; Safety; Treatment Outcome; Zoledronic Acid

2015

Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer.

Cancer, 2006, Aug-01, Volume: 107, Issue:3

Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Atrasentan; Biomarkers, Tumor; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Disease Progression; Dyspnea; Edema; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Pyrrolidines; Treatment Outcome; Zoledronic Acid

2006

Other Studies

2 other study(ies) available for zoledronic acid and Dyspnea

Article	Year
A 15-Year-Old Boy with Dyspnea and Vanishing Bones. American journal of respiratory and critical care medicine, 2020, 08-01, Volume: 202, Issue:3 Topics: Adolescent; Biopsy; Bone Density Conservation Agents; Dyspnea; Exudates and Transudates; Humans; Imaging, Three-Dimensional; Male; Membrane Glycoproteins; Osteolysis, Essential; Pleural Effusion; Ribs; Sirolimus; Tomography, X-Ray Computed; Zoledronic Acid	2020
Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:9 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Dyspnea; Female; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Zoledronic Acid	2010

Article

Year

A 15-Year-Old Boy with Dyspnea and Vanishing Bones.

American journal of respiratory and critical care medicine, 2020, 08-01, Volume: 202, Issue:3

Topics: Adolescent; Biopsy; Bone Density Conservation Agents; Dyspnea; Exudates and Transudates; Humans; Imaging, Three-Dimensional; Male; Membrane Glycoproteins; Osteolysis, Essential; Pleural Effusion; Ribs; Sirolimus; Tomography, X-Ray Computed; Zoledronic Acid

2020

Respiratory complications associated with IV zoledronic acid infusion in the treatment of postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2010, Volume: 21, Issue:9

Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Dyspnea; Female; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Zoledronic Acid

2010